These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 9323266

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics.
    Tiihonen J, Kuikka J, Bergström K, Hakola P, Karhu J, Ryynänen OP, Föhr J.
    Nat Med; 1995 Jul; 1(7):654-7. PubMed ID: 7585146
    [Abstract] [Full Text] [Related]

  • 4. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.
    Pirker W, Asenbaum S, Hauk M, Kandlhofer S, Tauscher J, Willeit M, Neumeister A, Praschak-Rieder N, Angelberger P, Brücke T.
    J Nucl Med; 2000 Jan; 41(1):36-44. PubMed ID: 10647603
    [Abstract] [Full Text] [Related]

  • 5. Comparison of [123I]beta-CIT and [123I]IPCIT as single-photon emission tomography radiotracers for the dopamine transporter in nonhuman primates.
    Scanley BE, al-Tikriti MS, Gandelman MS, Laruelle M, Zea-Ponce Y, Baldwin RM, Zoghbi SS, Hoffer PB, Charney DS, Wang S.
    Eur J Nucl Med; 1995 Jan; 22(1):4-11. PubMed ID: 7698153
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Iodine-123 labelled N-(2-fluoroethyl)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)nortropane for dopamine transporter imaging in the living human brain.
    Kuikka JT, Akerman K, Bergström KA, Karhu J, Hiltunen J, Haukka J, Heikkinen J, Tiihonen J, Wang S, Neumeyer JL.
    Eur J Nucl Med; 1995 Jul; 22(7):682-6. PubMed ID: 7498231
    [Abstract] [Full Text] [Related]

  • 8. Imaging of serotonin and dopamine transporters in the living human brain.
    Kuikka JT, Tiihonen J, Bergström KA, Karhu J, Hartikainen P, Viinamäki H, Länsimies E, Lehtonen J, Hakola P.
    Eur J Nucl Med; 1995 Apr; 22(4):346-50. PubMed ID: 7607266
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of iodine-123 labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and 2 beta-carbomethoxy-3 beta-(4-iodophenyl)-N-(3-fluoropropyl)nortropane for imaging of the dopamine transporter in the living human brain.
    Kuikka JT, Bergström KA, Ahonen A, Hiltunen J, Haukka J, Länsimies E, Wang S, Neumeyer JL.
    Eur J Nucl Med; 1995 Apr; 22(4):356-60. PubMed ID: 7607268
    [Abstract] [Full Text] [Related]

  • 11. Iodine-123 labeled nor-beta-CIT as a potential tracer for serotonin transporter imaging in the human brain with single-photon emission tomography.
    Hiltunen J, Akerman KK, Kuikka JT, Bergström KA, Halldin C, Nikula T, Räsänen P, Tiihonen J, Vauhkonen M, Karhu J, Kupila J, Länsimies E, Farde L.
    Eur J Nucl Med; 1998 Jan; 25(1):19-23. PubMed ID: 9396870
    [Abstract] [Full Text] [Related]

  • 12. Assessment of affinities of beta-CIT, beta-CIT-FE, and beta-CIT-FP for monoamine transporters permanently expressed in cell lines.
    Okada T, Fujita M, Shimada S, Sato K, Schloss P, Watanabe Y, Itoh Y, Tohyama M, Nishimura T.
    Nucl Med Biol; 1998 Jan; 25(1):53-8. PubMed ID: 9466362
    [Abstract] [Full Text] [Related]

  • 13. SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.
    Laruelle M, Baldwin RM, Malison RT, Zea-Ponce Y, Zoghbi SS, al-Tikriti MS, Sybirska EH, Zimmermann RC, Wisniewski G, Neumeyer JL.
    Synapse; 1993 Apr; 13(4):295-309. PubMed ID: 7683143
    [Abstract] [Full Text] [Related]

  • 14. In vitro and in vivo characterisation of nor-beta-CIT: a potential radioligand for visualisation of the serotonin transporter in the brain.
    Bergström KA, Halldin C, Hall H, Lundkvist C, Ginovart N, Swahn CG, Farde L.
    Eur J Nucl Med; 1997 Jun; 24(6):596-601. PubMed ID: 9169564
    [Abstract] [Full Text] [Related]

  • 15. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.
    Staley JK, Krishnan-Sarin S, Zoghbi S, Tamagnan G, Fujita M, Seibyl JP, Maciejewski PK, O'Malley S, Innis RB.
    Synapse; 2001 Sep 15; 41(4):275-84. PubMed ID: 11494398
    [Abstract] [Full Text] [Related]

  • 16. [123I] beta-CIT, a tracer for dopamine and serotonin re-uptake sites: preparation and preliminary SPECT studies in humans.
    Bergström KA, Kuikka JT, Ahonen A, Vanninen E.
    J Nucl Biol Med (1991); 1994 Dec 15; 38(4 Suppl 1):128-31. PubMed ID: 7632756
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [123I]beta-CIT single-photon emission tomography in Parkinson's disease reveals a smaller decline in dopamine transporters with age than in controls.
    Tissingh G, Bergmans P, Booij J, Winogrodzka A, Stoof JC, Wolters EC, Van Royen EA.
    Eur J Nucl Med; 1997 Sep 15; 24(9):1171-4. PubMed ID: 9283113
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT. Binding kinetics in the human brain.
    Brücke T, Kornhuber J, Angelberger P, Asenbaum S, Frassine H, Podreka I.
    J Neural Transm Gen Sect; 1993 Sep 15; 94(2):137-46. PubMed ID: 8110440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.